논문KCI 등재
Non-contrast magnetic resonance imaging outperforms contrast-enhanced computed tomography in preoperative detection of hepatocellular carcinoma: A paired validation study
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
관련 논문AI추천
Non-Contrast Abbreviated Magnetic Resonance Imaging: A Cost-Effective Rookie in Hepatocellular Carcinoma Surveillance for Cirrhotic PatientsChoi Won-Mook, Heo Subin거트앤리버 소화기연관학회협의회 · Gut and Liver2024 · 제18권 제1호Diagnosis of hepatocellular carcinoma: Which MRI contrast agent? Which diagnostic criteria?So Yeon Kim대한간학회 · Clinical and Molecular Hepatology2020 · 제26권 제3호Non-contrast magnetic resonance imaging for detection of late recurrent hepatocellular carcinoma after curative treatment: a prospective multicenter comparison to contrast-enhanced computed tomographyDong Ho Lee, Dong Wook Kim, Eun Ju Cho, Jai Young Cho, Jeon Sun Kyung, Jin-Wook Kim, Jonggi Choi, Jungheum Cho, Kwang-Woong Lee, Kyung-Suk Suh, So Yeon Kim, Su Jong Yu, Won Chang, Young-Suk Lim, Yun Bin Lee대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제4호Imaging diagnosis of hepatocellular carcinoma: Future directions with special emphasis on hepatobiliary magnetic resonance imaging and contrast-enhanced ultrasound이정민, Jeong Hee Yoon, Junghoan Park, Tae-Hyung Kim대한간학회 · Clinical and Molecular Hepatology2022 · 제28권 제3호CT Detection of Hepatocellular Carcinoma in Advanced Liver Cirrhosis: Correlation of Helical CT and Explanted Liver고광철, 김민주, 박성운, 박철권, 유위강, 임재훈, 임효근, 조재원대한간학회 · Clinical and Molecular Hepatology2002 · 제8권 제2002호Radiologic and Pathologic Discordance in Hepatocellular Carcinoma: More Than a Mismatch, with Prognostic SignificanceIjin Joo거트앤리버 소화기연관학회협의회 · Gut and Liver2025 · 제19권 제4호
이 간행물의 다른 논문 (76건)
2025 KASL clinical practice guidelines for management of hepatitis CEun Sun Jang, Eun Ju Cho, Chang Hun Lee, Do Seon Song, Nae-Yun Heo, Jae Yoon Jeong, Jung Gil Park, Jae Seung Lee, Jae Hyun Yoon, Seul Ki Han, Young Kul Jungpp. 1-52Critical considerations in evaluating the therapeutic potential of HK-660S for primary sclerosing cholangi tis: Letter to the editor on “Safety and efficacy of HK 660S in patients with primary sclerosing cholangitis: a randomized double-blind phase 2a trial”Yizi He, Haifeng He, Qi Liang, Yongzhi Xiepp. 1-3Letter to the editor on “Current burden of steatotic liv er disease and fibrosis among adults in the United States, 2017–2023”Sisi Yang, Zhenxuan Mapp. 4-6Letter to the editor on “Direct-acting antiviral therapy for patients with HCV-related hepatocellular carcino ma: a nationwide cohort study”Xiaodi Yang, Zhongqing Qian, Qiong Wang, Fuliang Chen, Xiaojing Wang, Deyan Chenpp. 7-9Letter to the editor on “GULP1 as a novel diagnostic and predictive biomarker in hepatocellular carcinoma”Juan Yang, Xinyi Li, Sheng Zhengpp. 10-12